𝔖 Bobbio Scriptorium
✦   LIBER   ✦

P109 Systemic mastocytosis with partial response to cladribine

✍ Scribed by N. Čolovič; M. Sretenovič; T. Terzič; M. Colovic; V. Jurišič

Book ID
104323160
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
62 KB
Volume
21
Category
Article
ISSN
0268-960X

No coin nor oath required. For personal study only.

✦ Synopsis

6/155), high white cell number (13/155) (red cell unit) or low thrombocyte number (14/125) (thrombocyte unit). Summary: Donors with low hemoglobin levels have to be excluded from the blood donation service for 3 months. So, in theory haemoglobin concentration of all total blood units is suitable for preparation the good quality basic units. If we systematically check the quality of the basic units, we can avoid or repair the technical faults of production.

CMPD, Friday 31 August 2007

P107 Chromosomal abnormalities in Philadelphia chromosome-negative metaphases appearing during imatinib mesylate therapy in patients with Philadelphia chromosome positive chronic myeloid leukemia in chronic phase

📜 SIMILAR VOLUMES

Response of severe systemic mastocytosis
Response of severe systemic mastocytosis to interferon alpha
✍ Butterfield 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 368 KB

Six patients with documented systemic mast cell disease were enrolled in a 1-year, phase I study to determine the possible benefits of interferon alpha-2b (IFN-alpha). IFN-alpha therapy was begun at a dosage of 0.5 million units/day (MU/day) by subcutaneous injection and increased, as tolerated, to

Quetiapine augmentation in depressed pat
Quetiapine augmentation in depressed patients with partial response to antidepressants
✍ James S Olver; Sophie Ignatiadis; Paul Maruff; Graham D Burrows; Trevor R Norman 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 1 views

## Abstract ## Objective Clinical trials suggest between 30–50% of depressed patients have an inadequate outcome to antidepressant pharmacotherapy. Among the approaches to improve outcome has been augmentation with antipsychotic medications. We aim to investigate the efficacy and tolerability of a

Cytoreductive therapy in 108 adults with
Cytoreductive therapy in 108 adults with systemic mastocytosis: Outcome analysis and response prediction during treatment with interferon-alpha, hydroxyurea, imatinib mesylate or 2-chlorodeoxyadenosine
✍ Ken H. Lim; Animesh Pardanani; Joseph H. Butterfield; Chin-Yang Li; Ayalew Teffe 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

## Abstract Cytoreductive therapy in systemic mastocytosis (SM) includes several drugs whose individual merit has not been well characterized. We retrospectively studied 108 Mayo Clinic patients who met the 2008 WHO diagnostic criteria for SM and received at least one cytoreductive drug. The number